Table 2.
Protocol # (Referenceb) |
Study | CTPs | N | Statusa |
---|---|---|---|---|
CTN 0001 | Buprenorphine/naloxone for inpatient detoxification | 6 | 113 | Completed (Ling, et al., 2005) |
CTN 0002 | Buprenorphine/naloxone for outpatient detoxification | 6 | 230 | Completed (Ling, et al., 2005) |
CTN 0003 | Comparison of two buprenorphine/naloxone taper schedules | 11 | 516 | Completed (Ling, et al., 2009) |
CTN 0004 | Motivational enhancement therapy for patients in treatment for substance use disorders | 6 | 496 | Completed (Ball, et al., 2007) |
CTN 0005 | Motivational interviewing for patients in treatment for substance use disorders | 5 | 423 | Completed (Carroll, et al., 2006) |
CTN 0006 | Low cost motivational incentives for stimulant-abusing patients in outpatient psychosocial treatment programs | 8 | 454 | Completed (Petry, et al., 2005) |
CTN 0007 | Low cost motivational incentives for stimulant-abusing patients in methadone maintenance treatment | 6 | 403 | Completed (Peirce, et al., 2006) |
CTN 0009 | Incorporating smoking cessation treatment into substance abuse treatment programs | 12 | 225 | Completed (Reid, et al., 2008) |
CTN 0010 | Buprenorphine/naloxone-facilitated rehabilitation for opioid-dependent adolescents and young adults | 6 | 154 | Completed (Woody, et al., 2008) |
CTN 0011 | Telephone enhancement procedure for long-term engagement in continuing care | 4 | 339 | Completed (Hubbard, et al., 2007) |
CTN 0013 | Motivational enhancement therapy for pregnant women in treatment for substance use disorders | 4 | 200 | Completed (Winhusen, et al., 2008) |
CTN 0014 | Brief Strategic Family Therapy for adolescents in treatment for substance use disorders | 8 | 457 | Manuscript in Preparation |
CTN 0015 | Seeking Safety therapy for women with PTSD in treatment for substance use disorders | 7 | 353 | Completed (Hien, et al., 2009) |
CTN0017 | HIV HCV risk reduction interventions for injection substance users | 8 | 632 | Manuscript in Preparation |
CTN 0018 | HIV/STD risk reduction interventions for men in treatment for substance use disorders | 14 | 594 | Completed (Calsyn, et al., 2009) |
CTN 0019 | HIV/STD risk reduction interventions for women in treatment for substance use disorders | 12 | 517 | Completed (Tross, et al., 2008) |
CTN 0020 | Job seekers training for patients in treatment for substance use disorders | 12 | 628 | Manuscript in Preparation |
CTN 0021 | Motivational enhancement therapy for Spanish-speaking patients in treatment for substance use disorders | 6 | 463 | Completed (In Press) |
CTN 0027 | Liver function in patients maintained on buprenorphine/naloxone or methadone | 9 | 1269 | Follow-up |
CTN 0028 | Osmotic-release methylphenidate for ADHD in adolescents in treatment for substance use disorders | 11 | 303 | Manuscript in Preparation |
CTN 0029 | Osmotic-release methylphenidate for ADHD in patients receiving smoking cessation treatment | 6 | 255 | Completed (In Press) |
CTN 0030 | Treatment of prescription opioid addiction | 11 | 648 | Follow-up |
CTN 0031 | Twelve-step engagement for patients in treatment for stimulant use disorders | 10 | 471 | Follow-up |
CTN 0032 | HIV rapid testing and counseling in substance abuse treatment programs | 12 | 1281 | Follow-up |
CTN 0037 | Exercise as an adjunctive treatment for substance use disorders | 10c | 330c | Protocol Development |
CTN 0044 | Web-delivered treatment for substance use disorders | 10c | 500c | Protocol Development |
CTN 0046 | Smoking cessation intervention for patients in treatment for stimulant use disorders | 12c | 528c | Protocol Development |
Status terminology
Completed: All protocol-defined research is finished and the primary paper has been accepted
Manuscript in preparation: All protocol-defined research is finished and the primary paper is in process
Follow-up: Participant enrollment is finished. Participant follow-up is ongoing.
See Reference section for full citation
Planned study parameters